1. What you get at review
DoseRelay is a passive self-titration log: the patient logs, the week compiles, and the clinician sees a structured PDF at a scheduled follow-up — not a live inbox to watch.
- No dose recommendations — no suggested doses or automatic schedule changes.
- Prescriber-in-the-loop — interpretation and dose decisions stay with the qualified UK prescriber.
- Review prep, not live monitoring — the patient brings the PDF to the appointment.
- Not a medical device — self-report logging for visit preparation; no automated diagnosis.
2. Data isolated by design
DoseRelay is not a clinic EMR. We do not use NHS numbers or legal names as the product primary key.
- Tokenised records: patients appear as opaque tokens (e.g.
Patient-AX92) in reports and storage. - Local mapping only: linking a token to a real identity stays inside the clinic’s own EMR / process.
- Isolated clinical data: the working set is self-log content under a token — not a full demographic dossier.
Real identity stays in clinic systems. The PDF uses a token only.
3. Bridging patient ease and clinical clarity
Patient-side: as easy as a voice note — text or voice in seconds.
Clinician-side: a structured, scannable summary ready for review — not a stream of unstructured messages to decode mid-appointment.
Days 1–7 low-effort input → PDF to patient → brought to review.
4. Data protection posture
- Encryption in transit: TLS for public endpoints.
- No public model training: patient logs are not used to train public foundation models.
- EU hosting: application infrastructure runs on EU-based servers (Hetzner).
Details: Privacy. Questions: [email protected].